Showing results (51-60 of 148) with videos related to

Sort By:
Pageof 15
Pharmacogenomics|August 5, 2006
Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humansCarmen Martínez, Felipe Martín, Juana M Fernández, et al.
Future Oncology (London, England)|June 11, 2024
Regorafenib in patients with metastatic colorectal cancer in Spain: from clinical trials to real-world evidenceAndres Cervantes, Josep Tabernero, Rocio Garcia-Carbonero, et al.
Electrophoresis|July 31, 2014
Evaluation of fritless solid-phase extraction coupled on-line with capillary electrophoresis-mass spectrometry for the analysis of opioid peptides in cerebrospinal fluidSilvia Medina-Casanellas, Yvonne H Tak, Fernando Benavente, et al.
Organic & Biomolecular Chemistry|September 8, 2016
Bicyclic isoureas derived from 1-deoxynojirimycin are potent inhibitors of β-glucocerebrosidaseAlen Sevšek, Maša Čelan, Bibi Erjavec, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 18, 2022
SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021)Jaume Capdevila, Ma Auxiliadora Gómez, Mónica Guillot, et al.
Nature Communications|October 25, 2023
Sialic acid O-acetylation patterns and glycosidic linkage type determination by ion mobility-mass spectrometryGaёl M Vos, Kevin C Hooijschuur, Zeshi Li, et al.
Cancer Chemotherapy and Pharmacology|April 9, 2005
A phase I, dose-finding study of irinotecan (CPT-11) short i.v. infusion combined with fixed dose of 5-fluorouracil (5-FU) protracted i.v. infusion in adult patients with advanced solid tumoursJavier Sastre, Luis Paz-Ares, Antonio Carcas, et al.
Clinical Colorectal Cancer|September 20, 2015
Risk-Adapted Adjuvant Chemotherapy After Concomitant Fluoropyrimidine-Radiotherapy Neoadjuvant Treatment for Patients With Resectable CT3-4 or N+ Rectal Cancer: Five-Year Disease-Free Survival Results of a Single-Center SeriesJavier Sastre, Juan Jose Serrano, Cristina Fernández, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Phase 1b dose escalation study of erlotinib in combination with infusional 5-Fluorouracil, leucovorin, and oxaliplatin in patients with advanced solid tumorsAxel-R Hanauske, Jim Cassidy, Javier Sastre, et al.
BMC Cancer|July 4, 2007
Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patientsGuillermo Gervasini, Elena García-Martín, José M Ladero, et al.
Pageof 15